Zynex Inc, a medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announces it has been ranked 416th in revenue growth among all companies in the US and Canada for revenue growth between 2018 and 2021 on Deloitte’s Technology Fast 500.
Zynex’s revenues grew 308% over that period, with 2021 revenue reaching $130.3 million. The company estimates 2022 revenue between $157.4 and $160.4 million.
“We are honored by the recognition of Zynex’s revenue growth by Deloitte’s Technology Fast 500 for the fourth year in a row,” said Thomas Sandgaard, CEO and founder of Zynex Inc. “I am extremely proud of our team’s accomplishments in driving revenue growth year-after-year, and believe this distinguished award reflects our commitment to long term market share gains and strategic goal execution.”
“This year’s Technology Fast 500 list is a true reflection of some of today’s most determined and inspiring pioneers who have prospered by anticipating what’s next, understanding what’s needed to succeed and driving creativity forward,” said Christie Simons, partner, Deloitte & Touche LLP and industry leader for technology, media and telecommunications within Deloitte’s audit & assurance practice. “Representing all facets of technology, the winners have shown they not only have the vision but can also expertly manage their companies through rapid growth. We congratulate each winner on their and impressive achievements.”
About Deloitte’s 2022 Technology Fast 500
Now in its 28th year, the Deloitte Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2018 to 2021.
In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues. Companies must have base-year operating revenues of at least $50,000, and current-year operating revenues of at least $5 million. Additionally, companies must be in business for a minimum of four years and be headquartered within North America.
[Source(s): Zynex, PR Newswire]
